Details of the Drug

General Information of Drug (ID: DMP6BDX)

• Drug Name: TLC178

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]

• Cross-matching ID:
  PubChem CID: 11607738
  TTD ID: D0G9MC

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)